Takeda Partners with KSU Medical City to Advance Healthcare Training in Saudi Arabia

Takeda, a leading global biopharmaceutical company, has announced a groundbreaking partnership with King Saud University Medical City (KSUMC) to enhance healthcare training for medical professionals across Saudi Arabia. This collaboration marks a significant step towards advancing the country’s healthcare sector through specialized training and knowledge-sharing initiatives.

Driving Innovation in Healthcare

The partnership is built on a foundation of knowledge exchange, professional training, research and development, and the integration of cutting-edge digital health and telemedicine solutions. These efforts align with Saudi Arabia’s Vision 2030 goals, which emphasize modernization and innovation in healthcare. The Memorandum of Collaboration (MoC) was officially signed during the recent Global Health Exhibition at the Riyadh Exhibition and Convention Centre. The event was attended by Prof. Ahmed bin Salah Hirsi, CEO of KSUMC, and Dr. Khaled Sary, General Manager of Takeda West Gulf Cluster.

KSUMC: A Hub of Medical Excellence

KSUMC, a premier medical institution in Riyadh, is renowned for its multidisciplinary approach and adoption of state-of-the-art medical technologies. The facility boasts a team of over 1,300 full-time physicians, 853 residents and fellows, and approximately 2,072 allied health professionals. Through this strategic collaboration, KSUMC aims to further enhance the expertise of its medical workforce by leveraging Takeda’s extensive research and innovation capabilities in key therapeutic areas, including oncology, rare diseases, neuroscience, gastrointestinal & inflammation, plasma-derived therapies, and vaccines.

“As we work toward elevating the quality of healthcare for the citizens of Saudi Arabia in line with Vision 2030, public-private partnerships will continue to play a vital role in achieving core objectives. Our collaboration with Takeda will be critical to advancing knowledge and skills training initiatives while providing access to the latest insights and innovations in the medical field. This will ensure that our healthcare practitioners are empowered to deliver the best patient care possible,” said Prof. Ahmed bin Salah Hirsi, CEO, King Saud University Medical City.

“With a shared appreciation for the values of patient-centricity and innovation, we believe our recent collaboration with the King Saud University Medical City will fundamentally enhance patient care in terms of diagnosis and treatment. By leveraging our complementary strengths–including KSUMC’s local expertise and Takeda’s global research and development capabilities–our collaborative efforts will support a more resilient healthcare ecosystem, better adapted to the needs of today’s patients.” said Dr. Khaled Sary, General Manager, Takeda West Gulf Cluster.

Commitment to Sustainable Healthcare

By addressing unmet medical needs and fostering a sustainable healthcare ecosystem, this alliance exemplifies Takeda’s dedication to driving medical advancements and improving patient care. The partnership not only underscores the importance of innovation in healthcare but also highlights Takeda’s ongoing commitment to empowering medical professionals across the region. Looking ahead, Takeda plans to expand its strategic collaborations across the Middle East to further enhance healthcare outcomes and accessibility.